HIGHLIGHTS
- who: Alan K. Burnett et al. from the (UNIVERSITY) have published the paper: Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses, in the Journal: (JOURNAL)
SUMMARY
The optimum number of treatment courses for younger patients with acute myeloid leukemia (AML) is uncertain. The United Kingdom National Cancer Research Institute AML17 trial randomly assigned patients who were not high risk to a total of three versus four courses. PATIENTS AND METHODS Patients received two induction courses based on daunorubicin and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.